Cargando…
Rapid On-Cell Selection of High-Performance Human Antibodies
[Image: see text] Phage display is a critical tool for developing antibodies. However, existing approaches require many time-consuming rounds of biopanning and screening of potential candidates due to a high rate of failure during validation. Herein, we present a rapid on-cell phage display platform...
Autores principales: | Philpott, David N., Gomis, Surath, Wang, Hansen, Atwal, Randy, Kelil, Abdellali, Sack, Tanja, Morningstar, Brandon, Burnie, Chris, Sargent, Edward H., Angers, Stephane, Sidhu, Sachdev, Kelley, Shana O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796304/ https://www.ncbi.nlm.nih.gov/pubmed/35106377 http://dx.doi.org/10.1021/acscentsci.1c01205 |
Ejemplares similares
-
CellectSeq: In silico discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing
por: Kelil, Abdellali, et al.
Publicado: (2021) -
In situ antibody phage display yields optimal inhibitors of integrin α11/β1
por: Gallo, Eugenio, et al.
Publicado: (2020) -
nuPRISM: Microfluidic
Genome-Wide Phenotypic Screening
Platform for Cellular Nuclei
por: Abdrabou, Abdalla M., et al.
Publicado: (2022) -
CLUSS: Clustering of protein sequences based on a new similarity measure
por: Kelil, Abdellali, et al.
Publicado: (2007) -
Fast and Accurate Discovery of Degenerate Linear Motifs in Protein Sequences
por: Kelil, Abdellali, et al.
Publicado: (2014)